This enzyme participates in nucleotide metabolism. It produces dUMP, the immediate precursor of thymidine nucleotides, and concurrently reduces intracellular dUTP levels, preventing uracil incorporation into DNA.
KEGG: cca:CCA_00347
STRING: 227941.CCA00347
Deoxyuridine 5'-triphosphate nucleotidohydrolase (dut) in Chlamydophila caviae serves two critical functions in nucleotide metabolism. First, it catalyzes the hydrolysis of dUTP to produce dUMP, which is the immediate precursor required for thymidine nucleotide biosynthesis. Second, it plays a crucial role in maintaining DNA integrity by decreasing the intracellular concentration of dUTP, thereby preventing the misincorporation of uracil into DNA during replication and repair processes . This function is particularly important in bacterial systems where maintaining genomic stability is essential for pathogen survival. The enzyme belongs to the broader dUTPase family, which is highly conserved across bacterial species, indicating its evolutionary significance in nucleotide metabolism pathways.
Comparative analysis of Chlamydophila caviae dut with orthologous proteins in related Chlamydial species reveals significant insights into evolutionary conservation and adaptation:
The dut gene exists within a core genome that is highly conserved across Chlamydophila species, with most of the variation occurring in membrane proteins and pathogenicity factors rather than metabolic enzymes . While the core enzymatic function remains consistent, subtle variations in sequence and structure may reflect adaptations to different host environments and infection strategies. Significantly, the conservation of dut across these species underscores its essential role in bacterial metabolism and potential value as a therapeutic target.
For optimal expression of recombinant Chlamydophila caviae dut, several expression systems can be considered based on research needs:
E. coli Expression System: The most common approach uses pET-based vectors with T7 promoter systems in E. coli BL21(DE3) or its derivatives. This system typically yields 10-20 mg of soluble protein per liter of culture under optimized conditions.
Methodology for Optimized Expression:
Culture conditions: Growth at 30°C rather than 37°C after induction often improves solubility
Induction: Lower IPTG concentrations (0.1-0.5 mM) and extended expression times (16-18 hours)
Buffer composition: Inclusion of 5-10% glycerol and 1-5 mM DTT in lysis buffers enhances stability
Purification Strategy:
His-tagged constructs allow for initial IMAC (immobilized metal affinity chromatography)
Size exclusion chromatography as a second step ensures high purity
Typical yields of >90% pure protein are achievable following this two-step purification
The recombinant protein can be expressed with various affinity tags (His, GST, MBP) to facilitate purification, with consideration given to the potential impact of these tags on enzymatic activity. For structural studies requiring tag removal, precision protease cleavage sites can be incorporated into the construct design.
Several complementary methods can be employed to assess the enzymatic activity of Chlamydophila caviae dut:
Spectrophotometric Assays:
Cresol Red Assay: Measures proton release during dUTP hydrolysis by monitoring absorbance changes at 573 nm
Coupled Enzyme Assay: Links dUMP production to subsequent enzymatic reactions that generate measurable spectrophotometric signals
HPLC-Based Methods:
Direct quantification of substrate (dUTP) consumption and product (dUMP) formation
Provides precise kinetic parameters (Km, kcat, kcat/Km)
Typical Km values for dUTPases range from 0.5-5 μM for dUTP
Isothermal Titration Calorimetry (ITC):
Measures heat released during catalysis
Provides thermodynamic parameters along with kinetic data
Can determine binding affinity for substrates and inhibitors
Malachite Green Assay:
Detects inorganic pyrophosphate (PPi) released during the reaction
Simple colorimetric detection at 630 nm
Standard reaction conditions typically include: Tris-HCl buffer (pH 7.5-8.0), 5-10 mM MgCl₂ (cofactor), 1-100 μM dUTP (substrate), and controlled temperature (25-37°C). Proper enzyme dilution is essential to ensure linear reaction rates during initial velocity measurements.
Deoxyuridine 5'-triphosphate nucleotidohydrolase plays a multifaceted role in Chlamydophila caviae survival and pathogenicity:
Genomic Integrity Maintenance: By preventing uracil incorporation into DNA, dut helps maintain the integrity of the chlamydial genome during the rapid replication that occurs in reticulate bodies (RBs). This is particularly critical in Chlamydophila species, which undergo unique biphasic developmental cycles with intensive DNA replication phases .
Nucleotide Pool Regulation: The enzyme regulates the balance between dUTP and dTTP pools, which is essential for proper DNA replication and repair. This regulation is especially important in intracellular pathogens that rely on host nucleotide precursors.
Host-Pathogen Interface: Research suggests that dut activity may influence host inflammatory responses by affecting nucleotide-sensing pathways. The enzyme's presence in the context of Chlamydophila caviae infection may modulate host cell responses through altered nucleotide signaling.
Developmental Cycle Progression: Proteomic studies of related Chlamydia species indicate that dUTPase activity varies between the infectious elementary body (EB) and the replicative reticulate body (RB) forms, suggesting stage-specific roles in the chlamydial developmental cycle .
The importance of dut is underscored by its conservation across Chlamydophila species despite the considerable genome reduction these obligate intracellular pathogens have undergone through evolution. This conservation suggests strong selective pressure to maintain dut function, making it a potential target for antibacterial strategies.
Site-directed mutagenesis studies provide critical insights into structure-function relationships of Chlamydophila caviae dut:
| Motif | Conserved Residues | Mutation Effects | Functional Significance |
|---|---|---|---|
| Motif I | DPE (Asp-Pro-Glu) | D→N: >95% activity loss | Metal coordination |
| Motif II | QLRP (Gln-Leu-Arg-Pro) | R→K: >80% activity loss | Substrate binding |
| Motif III | GLS (Gly-Leu-Ser) | G→A: Structural destabilization | Conformational flexibility |
| Motif IV | FIII (Phe-Ile-Ile-Ile) | F→Y: Minimal effect | Hydrophobic core stability |
| Motif V | GEEG (Gly-Glu-Glu-Gly) | E→Q: Severe catalytic defect | Catalytic water positioning |
Mutations in the predicted catalytic residues typically result in proteins that retain structural integrity but show dramatically reduced catalytic efficiency. Circular dichroism spectroscopy can confirm that these mutations do not significantly alter secondary structure content, while thermal denaturation studies often reveal subtle changes in protein stability.
The most informative mutations target: (1) the predicted catalytic aspartate that coordinates magnesium, (2) the conserved arginine involved in triphosphate binding, and (3) residues forming the uracil-binding pocket that confer nucleotide specificity. These structure-function studies not only elucidate the catalytic mechanism but also provide valuable information for the rational design of specific inhibitors.
Researchers face several specific challenges when attempting to crystallize Chlamydophila caviae dut:
Protein Stability Issues:
The enzyme may exhibit conformational heterogeneity, particularly in the C-terminal region
Buffer optimization critical: screening with various pH ranges (6.5-8.5) and salt concentrations (50-300 mM NaCl)
Addition of divalent cations (5-10 mM MgCl₂) and nucleotide analogs often enhances stability
Crystallization Bottlenecks:
Initial crystallization hits frequently yield microcrystals requiring extensive optimization
Successful approaches include:
Sitting-drop vapor diffusion with PEG-based precipitants (PEG 3350, 20-25%)
Inclusion of nucleotide analogs (dUMP, dUDP, or non-hydrolyzable dUTP analogs)
Seeding techniques to improve crystal quality
Structural Analysis Complexities:
Potential conformational changes between apo, substrate-bound, and product-bound states
Order-disorder transitions in functional loop regions
Oligomerization state may differ between solution and crystal
Successful structural determination typically requires multiple approaches, including co-crystallization with substrate analogs, product molecules, or inhibitors to stabilize specific conformational states. Molecular replacement using related dUTPase structures as search models is generally successful for phase determination, as the core fold is well conserved across the dUTPase family.
Comparative analysis between Chlamydophila caviae dut and human dUTPase reveals important differences that can be exploited for therapeutic targeting:
Despite sharing the core dUTPase fold and catalytic mechanism, the bacterial and human enzymes exhibit subtle differences in active site architecture that can be exploited for selective inhibitor design. The bacterial enzyme typically shows distinct patterns of sensitivity to nucleotide analogs and small molecule inhibitors compared to its human counterpart.
These differences provide the structural basis for developing pathogen-specific inhibitors that target Chlamydophila caviae dut without affecting human dUTPase activity, potentially minimizing side effects in therapeutic applications.
Evolutionary analysis of Chlamydophila caviae dut provides important insights into bacterial adaptation and genome evolution:
Conservation Patterns:
The dut gene is part of the 842 conserved coding sequences shared between Chlamydophila caviae and Chlamydophila abortus, indicating its essential role in chlamydial biology
The high conservation of dut contrasts with significant variation in other gene families like membrane proteins and secretion systems
Selective Pressure Analysis:
dut shows evidence of purifying selection (dN/dS ratios typically <1), emphasizing its essential metabolic function
This conservation occurs despite considerable genome reduction in Chlamydophila species, highlighting its indispensable role
Genomic Context:
Functional Adaptation:
The maintained functionality of dut across diverse Chlamydophila species with different host tropisms suggests it represents a core metabolic function essential for intracellular survival
This contrasts with variability in other gene families such as those encoding polymorphic membrane proteins (Pmps) and transmembrane head (TMH) proteins that show greater diversification
The retention of functional dut in Chlamydophila caviae and related species that have undergone significant genome reduction highlights the essential nature of uracil exclusion from DNA even in highly host-adapted bacterial pathogens. This evolutionary conservation makes dut an attractive target for broad-spectrum therapeutic development against chlamydial infections.
Targeting Chlamydophila caviae dut presents several promising biomedical applications:
Antimicrobial Development:
Nucleotide analogs that competitively inhibit dut could disrupt bacterial DNA replication
Structure-based drug design strategies focusing on active site differences between bacterial and human enzymes
Potential inhibitor classes:
Modified uracil derivatives with altered sugar or phosphate moieties
Transition state analogs mimicking the pentacoordinate phosphorus intermediate
Allosteric inhibitors targeting trimeric interface regions
Diagnostic Applications:
Development of nucleic acid amplification tests targeting the dut gene for detecting Chlamydophila caviae
Particularly valuable for differentiating C. caviae-like strains from C. trachomatis in clinical specimens
Potential application in diagnosing C. caviae-like infections in humans, which were found in 8.9% of specimens from patients with cervicitis or urethritis
Vaccine Development:
Recombinant dut as a potential component in subunit vaccines against chlamydial infections
Chimeric constructs linking dut to immunogenic epitopes from surface antigens to enhance immune recognition
Research Tools:
Recombinant dut as a tool for studying nucleotide metabolism in bacterial systems
Reporter constructs utilizing dut activity for high-throughput screening of inhibitors
The biological significance of dut, combined with its structural differences from the human ortholog, positions it as a promising target for next-generation antibiotics against Chlamydophila infections, which could address the growing concern of antimicrobial resistance in these pathogens.
Rigorous determination of Chlamydophila caviae dut kinetic parameters requires careful experimental design:
Steady-State Kinetics Protocol:
Sample Preparation: Recombinant enzyme at 10-50 nM concentration, depending on specific activity
Reaction Conditions: 50 mM Tris-HCl (pH 7.8), 5 mM MgCl₂, 1 mM DTT, 25°C
Substrate Range: dUTP concentrations from 0.1-100 μM (spanning 0.1× to 10× expected Km)
Data Collection: Initial rates measured at ≤10% substrate conversion to ensure steady-state conditions
Analytical Methods Comparison:
| Method | Advantages | Limitations | Typical Precision |
|---|---|---|---|
| HPLC | Direct product quantification | Equipment intensive | ±5% |
| Spectrophotometric | Real-time monitoring | Indirect measurement | ±7-10% |
| Malachite Green | High sensitivity | End-point assay | ±8% |
| Radioactive | Highest sensitivity | Safety concerns, specialized facilities | ±3% |
Data Analysis Framework:
Michaelis-Menten equation: v = Vmax[S]/(Km+[S])
Lineweaver-Burk, Eadie-Hofstee, and Hanes-Woolf plots for graphical validation
Non-linear regression using enzyme kinetics software (GraphPad Prism, DynaFit)
Statistical validation through residual analysis and confidence interval determination
Parameter Reporting Standards:
kcat (s⁻¹): Turnover number calculated from Vmax/[E]t
Km (μM): Substrate concentration at half-maximal velocity
Catalytic efficiency: kcat/Km (M⁻¹s⁻¹)
Experimental conditions clearly specified (temperature, pH, buffer composition)
For inhibition studies, similar approaches apply with the addition of varying inhibitor concentrations and determination of inhibition constants (Ki) and mechanisms (competitive, non-competitive, uncompetitive, or mixed).
Advanced proteomic techniques provide powerful tools for analyzing dut expression in Chlamydophila caviae:
Quantitative Proteomic Strategies:
LC-MS^E Approach: Enables determination of absolute protein concentrations (molecules per cell) as demonstrated in similar studies with C. trachomatis
iTRAQ Labeling: Allows multiplexed comparison of protein levels across different developmental stages
SILAC: For studying host-pathogen proteome interactions when using cell culture models
Sample Preparation Protocols:
Differential centrifugation for separation of elementary bodies (EBs) and reticulate bodies (RBs)
Specialized extraction buffers containing chaotropes and detergents to solubilize membrane-associated proteins
Enzymatic or chemical digestion optimized for chlamydial proteins
Data Analysis Framework:
Protein identification using species-specific databases
Normalization strategies accounting for differences in developmental forms
Statistical methods for determining significant changes in protein abundance
Comparative Approaches:
Cross-species comparison of dut expression patterns
Correlation with transcriptomic data to identify post-transcriptional regulation
Integration with metabolomic data to relate enzyme levels to nucleotide pool dynamics
Based on studies of related chlamydial species, these approaches can reveal how dut expression varies between the infectious elementary body and the replicative reticulate body forms, providing insights into the role of this enzyme during different stages of the developmental cycle . Such quantitative data can also estimate the cellular investment in dut synthesis relative to other proteins, indicating its metabolic priority within the cell.
Rational design of Chlamydophila caviae dut inhibitors requires systematic consideration of several factors:
Structural Targeting Strategies:
Active Site Inhibitors: Focus on modifications of the uracil base, deoxyribose sugar, or phosphate groups
Allosteric Inhibitors: Target protein-protein interfaces in the trimeric structure
Covalent Inhibitors: Design reactive groups that form irreversible bonds with conserved cysteines
Selectivity Design Principles:
Exploit subtle differences in active site architecture between bacterial and human dUTPases
Target bacterial-specific binding pockets adjacent to the active site
Optimize inhibitor properties to enhance bacterial penetration while limiting human cell uptake
Medicinal Chemistry Optimization Framework:
| Parameter | Optimization Target | Measurement Method | Significance |
|---|---|---|---|
| Potency | IC₅₀ < 100 nM | Enzyme inhibition assay | Primary activity measure |
| Selectivity | >100-fold vs. human dUTPase | Comparative inhibition assay | Safety margin |
| Antimicrobial Activity | MIC < 1 μg/mL | Broth microdilution | Whole-cell efficacy |
| Cytotoxicity | CC₅₀ > 50 μM | MTT/XTT assay | Therapeutic window |
| Solubility | >20 μg/mL | Kinetic solubility assay | Formulation potential |
Computational Approaches:
Structure-based virtual screening of compound libraries against known or modeled dut structures
Molecular dynamics simulations to identify transient binding pockets
Quantitative structure-activity relationship (QSAR) models to guide analog design
Lead Optimization Considerations:
Balance of potency, selectivity, and physiochemical properties
Modifications to improve cell penetration in intracellular pathogens
Strategies to minimize efflux from bacterial cells
The development pathway typically progresses from high-throughput screening of fragment libraries to hit validation, structure-guided optimization, and finally in vitro and cell-based efficacy testing. Throughout this process, maintaining selectivity over human dUTPase remains a critical consideration to avoid potential toxicity issues.
Recombinant Chlamydophila caviae dut serves multiple functions as a versatile research tool:
Biochemical Applications:
Control enzyme for studying nucleotide metabolism pathways
Reference standard for developing nucleotide detection methods
Template for protein engineering studies of enzyme mechanism
Structural Biology Applications:
Model system for studying conformational changes during catalysis
Platform for fragment-based drug discovery approaches
Educational tool for demonstrating structure-function relationships
Assay Development Applications:
Component in coupled enzyme assays for monitoring other nucleotide-metabolizing enzymes
Tool for developing high-throughput screening platforms
Standard for validating novel enzyme activity detection methods
Antibody Production:
Immunogen for generating specific antibodies for detection and localization studies
Target for developing detection reagents in diagnostic applications
Experimental Protocol Applications:
Nucleotide Pool Cleanup:
Pre-treatment of reaction mixtures to eliminate dUTP contamination
Typical protocol: Incubate samples with 100 nM enzyme for 15 minutes at 37°C
DNA Amplification Enhancement:
Addition to PCR reactions to prevent uracil incorporation during amplification
Typical usage: 0.1 units per 50 μL PCR reaction
The high stability and well-characterized activity of recombinant dut make it particularly valuable as a reagent in molecular biology applications requiring control of nucleotide pool composition and purity.
Investigating Chlamydophila caviae dut in its native biological context presents unique challenges:
Cultivation Barriers:
Obligate intracellular lifestyle necessitates cell culture systems
Difficulty synchronizing developmental cycle for stage-specific analysis
Challenges in generating sufficient biomass for biochemical studies
Genetic Manipulation Limitations:
Limited genetic tools for chlamydial species
Challenges in creating targeted gene knockouts or mutations
Difficulty in complementing potential dut mutations due to intracellular lifestyle
Analytical Challenges:
Separating bacterial proteins from host cell background
Measuring enzyme activity in the context of host nucleotide pools
Distinguishing bacterial metabolism from host cell processes
Methodological Approaches to Overcome Limitations:
Cell Culture Systems:
Infection of susceptible cell lines (McCoy, HeLa)
Differential centrifugation to isolate bacterial forms
Density gradient purification to separate elementary and reticulate bodies
Genetic Approaches:
RNA interference techniques to knock down expression
Expression of dominant-negative mutants
Recently developed transformation systems using shuttle vectors
Imaging Approaches:
Immunofluorescence using anti-dut antibodies to track localization
Correlative light and electron microscopy for ultrastructural studies
Live-cell imaging with fluorescent nucleotide analogs
These technical challenges explain why most studies of chlamydial dut rely on recombinant protein expression and in vitro characterization rather than native context analysis, highlighting the need for continued development of genetic and biochemical tools for studying obligate intracellular bacteria.